CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock	Paid in Capital	Retained Earnings/Accumulated (Deficit)
Beginning Balances at Dec. 31, 2019	$ 42,065,916	$ 93,303	$ 40,329,502	$ 1,643,111
Beginning Balance, shares at Dec. 31, 2019		9,330,297
Restricted stock grants issued		$ 259	(259)
Restricted stock grants issued, Shares		25,905
Stock-based compensation	29,162		29,162
Net income (loss)	(356,424)			(356,424)
Dividends	(606,469)			(606,469)
Ending Balance at Mar. 31, 2020	41,132,185	$ 93,562	40,358,405	680,218
Ending Balance, shares at Mar. 31, 2020		9,356,202
Beginning Balances at Dec. 31, 2020	$ 40,038,891	$ 93,431	40,455,409	(509,949)
Beginning Balance, shares at Dec. 31, 2020	9,343,118	9,343,118
Restricted stock grants issued		$ 635	(635)
Restricted stock grants issued, Shares		63,475
Stock-based compensation	$ 31,706		31,706
Net income (loss)	411,247			411,247
Dividends	(607,303)			(607,303)
Ending Balance at Mar. 31, 2021	$ 39,874,541	$ 94,066	$ 40,486,480	$ (706,005)
Ending Balance, shares at Mar. 31, 2021	9,406,593	9,406,593